Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

Clinical trial NCT04425200 · COMPLETED

Trial details

NCT number: NCT04425200
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Neoplasms

Start date: 2020-07-29
Primary completion: 2020-12-18
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.